​Biotechnology company Lipella Pharmaceuticals Inc. files for Chapter 11 bankruptcy months after facing Nasdaq delisting.

In connection with the Chapter 11 cases, the Company expects to seek customary “first-day” relief that, if approved by the Court, would allow it to continue day-to-day operations, including ...

The company was delisted from Nasdaq last year after noncompliance issues. Now it plans a sale process to maximize value for ...

NanoString’s GeoMX Digital Spatial Profiler was at the heart of a patent lawsuit filed by 10x Genomics. (NanoString Image) Seattle-based publicly traded biotech company NanoString Technologies ...

Biotech technicians working in the lab. The biotechnology industry had a rough year in 2023 with more than two dozen companies filing for bankruptcy. The rise in bankruptcies last year came after 20 ...